In Phase A, participants will acquire distinct doses and schedules of oral ABBV-744 tablet to discover safe dosing routine. Supplemental participants might be enrolled in the recognized monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 will likely be supplied as "add-on" therapy. In Segment C, https://tuckerd443rdn6.ja-blog.com/profile